# The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals

> **NCT06550271** · — · COMPLETED · sponsor: **AgelessRx** · enrollment: 67 (actual)

## Conditions studied

- Aging

## Interventions

- **DRUG:** Rapamycin

## Key facts

- **NCT ID:** NCT06550271
- **Lead sponsor:** AgelessRx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-25
- **Primary completion:** 2023-12-15
- **Final completion:** 2023-12-15
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2024-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06550271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06550271, "The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06550271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*